Literature DB >> 24385717

A case of Mycoplasma pneumoniae-associated encephalomyelitis in a 16-year-old female presenting to an adult teaching hospital.

Hieu Tran1, Anthony Allworth1, Cameron Bennett1.   

Abstract

We report a rare cause of encephalitis that is not often described in the adult clinical setting. Our case was a 16-year-old female who presented with a clinical picture of viral encephalitis; however, magnetic resonance imaging showed a demyelinating lesion of the left frontal lobe. In this age group, differential diagnoses of acute demyelination encephalomyelitis and multiple sclerosis were entertained. Further investigations demonstrated positive Mycoplasma pneumoniae serology. As a result, a diagnosis of Mycoplasma pneumoniae-associated encephalitis was made based on a process of exclusion.

Entities:  

Keywords:  Mycoplasma pneumonia; demyelination; encephalitis

Year:  2013        PMID: 24385717      PMCID: PMC3873169          DOI: 10.4137/CCRep.S13309

Source DB:  PubMed          Journal:  Clin Med Insights Case Rep        ISSN: 1179-5476


Introduction

Neurologic complications from Mycoplasma pneumoniae have been known since the 1940s.1 Encephalitis is the most common complication, and occurs most often in children. A review by Lerer and Kalavsky2 found that 53% of patients with central nervous system (CNS) disease associated with M. pneumoniae were between the ages 6 years and 20 years. It is estimated that between 5% and 10% of acute childhood encephalitis in Europe and North America is attributable to M. pneumoniae.3 There is a spectrum of clinical manifestations such as aseptic meningitis, peripheral neuropathy, transverse myelitis, cranial nerve palsies, cerebellar ataxia, acute transverse myelitis, and acute disseminated encephalomyelitis.4 The incidence of these manifestations has been estimated to be between 0.06% and 0.1%,5 but CNS symptoms are reported in up to 7% of patients in the hospital setting with confirmed M. pneumoniae infection.6 Long-term neurological problems have been noted in 20%–60% of cases, with severe disease resulting in mental retardation, brain atrophy, hydrocephalus, epilepsy, visual changes, and global neurologic deficits with brainstem dysfunction and cerebellar ataxa.7 Two studies have shown that between 24% and 30% of patients require intensive care treatment, with mortality rates of between 8% and 10%.8,9

Case Report

The index patient presented with a 2-week history of head-aches, fevers, and dry cough. She then developed 3 days of diplopia, ataxia, and painful peripheral neuropathy. Her examination revealed an ataxic gait with normal muscle power, reflexes, and skin sensation. There was diplopia but no papilledema or other significant examination findings. A chest radiograph showed no abnormalities. Initial computed tomography imaging of her brain showed a single hypodense white matter lesion in the left frontal lobe. A subsequent magnetic resonance imaging scan (MRI) of the brain demonstrated a corresponding T2 and fluid-attenuated inversion recovery (FLAIR) hyperintense lesion in the left frontal lobe (Fig. 1). This raised the suspicion of acute demyelinating encephalomyelitis. Given the patient’s age and symptoms, a diagnosis of multiple sclerosis was also considered. Table 1 shows the results of the cerebrospinal fluid (CSF) analysis.
Figure 1

T2 axial images demonstrating the left frontal lobe demyelinating lesion.

Table 1

Cerebrospinal fluid analysis on admission.

WBC61 × 106/L (<5)
Polymorphs 2%
Mononuclear 98%
RBC2 × 106/L (<5)
Glucose3.0 mmol/L (2.2–3.9)
Protein300 mg/L (150–500)
No organisms seen on gram stain
M. Pneumonia DNA (NAA) Not detected
India Ink: Negative
Cryptococcal Ag (latex) Non-reactive
HSV 1 DNA (NAA) Not detected
HSV 2 DNA (NAA) Not detected
Varicella Zoster DNA (NAA) Not detected
CMV DNA (NAA) Not detected
EBV DNA (NAA) Not detected
The patient was started on empirical intravenous acyclovir. Other investigations revealed a positive total M. pneumoniae serology immunoglobulin (Ig)M antibody titer of >1,280. The diagnosis of M. pneumoniae-related CNS disease was made based on the patient’s clinical symptoms, positive serology, and the mononuclear pleocytosis found in the CSF. This is typically in the range of 10–200 cells/μL for M. pneumoniae-associated CNS infections.10 Routine CSF gram stain and bacterial cultures are characteristically negative. One review of 58 cases showed a diagnosis was made in 84% of patients with positive serology, 14% with CSF polymerase chain reaction (PCR), and 2% with CSF antibody determination.11 Our laboratory was able to evaluate the CSF for the open reading frame (ORF) 521 nuclear capsid protein gene with PCR, which returned a negative result. Acyclovir was ceased 3 days into hospital admission, and the patient was prescribed a course of oral doxycycline. The patient’s symptoms resolved over a period of 1 week of observation in hospital. Further analysis of the CSF with isoelectric focusing revealed oligoclonal bands of IgG in the CSF that was not present in the serum. The IgG index (CSF/serum) was 0.90 (<0.70). Two subsequent cranial MRI scans of the patient were obtained over a period of 3 months in the outpatient setting, and they showed the stable appearance of the left frontal lobe lesion. MRI of the spine did not show any demyelinating plaques. The patient had no recurrence of symptoms.

Discussion

The positive oligoclonal bands in the CSF are likely related to the immunological phenomena that are commonly linked to M. pneumoniae infections. It has been known since the 1970s that polyclonal B-cell activation and antibodies to brain tissue have been demonstrated in M. pneumoniae infections. 12 In 1996, Nishimura et al.13 reported three cases of M. pneumoniae encephalitis with associated anti-galactocerebroside antibodies. In this patient, a moderately positive anti-ganglioside GQ1b antibody was found. Komatsu et al14 had also reported this association in 1998. This supports the hypothesis that demyelination and neurologic dysfunction in this entity could be mediated by the immune system. The pathogenesis of M. pneumoniae CNS disease is unclear, but it may be related to direct invasion (proven during brain biopsy culture15 or nucleic acid hybridization16) or autoimmunity (immune complexes, cross-reacting antibodies, or a neurotoxin effect).17 This case highlights a rare cause of encephalitis in a patient presenting to a tertiary-level adult teaching hospital.
  17 in total

1.  Central nervous system complications of primary atypical pneumonia.

Authors:  L YESNICK
Journal:  AMA Arch Intern Med       Date:  1956-01

Review 2.  Mycoplasma pneumoniae pneumonia.

Authors:  J K Mansel; E C Rosenow; T F Smith; J W Martin
Journal:  Chest       Date:  1989-03       Impact factor: 9.410

3.  Acute transverse myelitis complicating pneumonia; report of a case.

Authors:  A I SUCHETT-KAYE
Journal:  Lancet       Date:  1948-09-11       Impact factor: 79.321

4.  Direct invasion of the brain parenchyma by Mycoplasma pneumoniae.

Authors:  J Launes; A Paetau; K Linnavuori; M Iivanaineu
Journal:  Acta Neurol Scand       Date:  1997-06       Impact factor: 3.209

Review 5.  Mycoplasma pneumoniae central nervous system infections.

Authors:  Florian Daxboeck
Journal:  Curr Opin Neurol       Date:  2006-08       Impact factor: 5.710

Review 6.  Diagnosis, treatment, and prognosis of Mycoplasma pneumoniae childhood encephalitis: systematic review of 58 cases.

Authors:  Florian Daxboeck; Alexander Blacky; Rainer Seidl; Robert Krause; Ojan Assadian
Journal:  J Child Neurol       Date:  2004-11       Impact factor: 1.987

7.  Post-infectious encephalitis with anti-galactocerebroside antibody subsequent to Mycoplasma pneumoniae infection.

Authors:  M Nishimura; T Saida; S Kuroki; T Kawabata; H Obayashi; K Saida; T Uchiyama
Journal:  J Neurol Sci       Date:  1996-09-01       Impact factor: 3.181

8.  Mycoplasma pneumoniae meningoencephalitis and cerebellitis with antiganglioside antibodies.

Authors:  H Komatsu; S Kuroki; Y Shimizu; H Takada; Y Takeuchi
Journal:  Pediatr Neurol       Date:  1998-02       Impact factor: 3.372

Review 9.  Mycoplasma pneumoniae ecephalitis.

Authors:  Ari Bitnun; Elizabeth Ford-Jones; Susan Blaser; Susan Richardson
Journal:  Semin Pediatr Infect Dis       Date:  2003-04

Review 10.  Mycoplasma pneumoniae-associated myelitis: a comprehensive review.

Authors:  S Tsiodras; Th Kelesidis; I Kelesidis; K Voumbourakis; H Giamarellou
Journal:  Eur J Neurol       Date:  2006-02       Impact factor: 6.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.